-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals
only, see how to do it
.
When insulin is injected subcutaneously, the maximum absorption peak appears in 1~2h, the rise and fall of the absorption curve is relatively smooth, and the insulin effect is relatively stable
.
Although every patient knows that insulin needs to be injected subcutaneously, it is not uncommon for insulin injections to occur into the muscle layer instead of under the skin
.
Studies have shown that the incidence of intramuscular injection in adults is 12%~34%.
When insulin is injected intramuscularly, the following problems are prone to occur:
Where to see more endocrinology clinical knowledge? Come to the "Doctor Station" and take a look 👇 at the references:[1] Luo Yingying, Ji Linong.
Analysis of misunderstanding of insulin injection technology and recommendation of international norms[J].
Chinese Journal of Diabetes,2011,03(3):267-270.
) Ji Linong, Guo Xiaohui, Jin J, et al.
Technical Guidelines for Diabetes Drug Injection in China (2016 Edition)[J].
Chinese Journal of Diabetes, 2017(2):79-105 [3] Chinese Journal of Diabetes Guidelines and Consensus Writing Committee.
Chinese Diabetes Drug Injection Technical Guidelines (2016 Edition)[J].
Chinese Journal of Diabetes,2017,9(2):79-105.
) [4] Diabetes Branch of Chinese Medical Association.
Chinese expert consensus on the prevention and treatment of subcutaneous lipoplasia associated with insulin injection[J].
Chinese Journal of Diabetes, 2021, 13(12):8
only, see how to do it
In the past 30 years, the prevalence of diabetes in China has increased
significantly.
Although the discovery and clinical application of insulin have greatly improved the clinical outcomes of diabetic patients, the blood glucose compliance rate of diabetic patients in China is still unsatisfactory
.
The patient's lack of knowledge about insulin injection may be an important cause
of poor glycemic control.
It is November 7th Insulin Standard Injection Day, today, let's take a look at what are the common problems in the insulin injection process and learn the solutions together!
Problem 1: The injection depth is not accurately controlled
.
When insulin is injected subcutaneously, the maximum absorption peak appears in 1~2h, the rise and fall of the absorption curve is relatively smooth, and the insulin effect is relatively stable
.
Although every patient knows that insulin needs to be injected subcutaneously, it is not uncommon for insulin injections to occur into the muscle layer instead of under the skin
.
Studies have shown that the incidence of intramuscular injection in adults is 12%~34%.
When insulin is injected intramuscularly, the following problems are prone to occur:
Abnormal insulin absorption;
poor blood sugar control, fluctuations in blood sugar, unexplained hypoglycemia;
Bleeding, bruising, pain
.
In order to ensure that insulin is injected into the subcutaneous layer, patients should check the injection site before each injection, in general, obese patients do not need to pinch the abdomen, while emaciated patients need to pinch the skin; Women's thighs do not need to be pinched and injected, and men's thighs need to be pinched and injected; There is no need for pinching injections in the buttocks
.
If insulin is injected with a long insulin pen needle or insulin syringe, it must be pinched or injected at a 45-degree angle
.
Figure 1 Injection sites for patients of different body types
Figure 2 Correct kneading method
At the same time, the correct selection of the right length of needle is crucial, shorter needles are safer and often better tolerated by patients
.
The short needle ensures that the drug is injected into the subcutaneous tissue and significantly reduces the risk of
hypoglycemia caused by injection into the muscle layer.
Figure 3 Percentage of risk of intramuscular injection due to needle injection of different lengths
Problem 2: The injection site is not rotated
Failure to rotate the injection site correctly is an independent risk factor for the development of subcutaneous lipoplasia, and studies have found that subcutaneous lipoplasia is found in nearly two-thirds of patients, 98% of whom have either the injection site or the rotation method is incorrect
.
Some patients even deliberately choose the subcutaneous fat hyperplasia site for injection
because the injection is not painful.
Compared with injection into normal subcutaneous adipose tissue, insulin injection into the site of subcutaneous fat hyperplasia will significantly reduce insulin absorption, increase blood glucose fluctuations, significantly reduce insulin peak concentration by 34%, the effect of insulin on blood glucose decreased by 27% in the first 4 hours, and the postprandial blood glucose concentration increased significantly, increasing by 58% 2-5 hours after injection, which has significant negative effects
on insulin absorption and postprandial blood sugar control.
In fact, most patients who inject insulin for a long time do not know that the injection site should be rotated during injection, and it is more likely that they will not rotate the site correctly or are psychologically unwilling to rotate the site
.
For psychological problems, health care providers can adjust
appropriately by frequently emphasizing to patients the short- and long-term benefits of good glycemic management.
At the same time, patients should be made aware that if insulin is injected into the tissue with subcutaneous fat hyperplasia, it will often lead to the use of larger doses of insulin to control blood sugar, and the result will affect the treatment effect and increase the cost of treatment, which is not worth the loss
.
At the same time, the psychological problems
caused by the pain caused by the injection should not be ignored.
Doing the following can help reduce the pain caused by injections:
- Opened insulin should be stored at room temperature;
- If alcohol is used for disinfection, wait for the alcohol to completely evaporate before injection;
- Avoid injections at the roots of the hair;
- Use shorter and thinner needles;
- A new needle is used for each injection
.
For patients who will not rotate the injection position correctly, we can refer to the "Chinese Diabetes Drug Refraction Technical Guidelines (2016 Edition)" on the recommendation of injection site rotation:
1) A proven injection site rotation protocol: divide the injection site into four equal zones (thighs or buttocks can be divided into two equal zones), use one equal zone per week and always rotate clockwise
.
Figure 4 Correct rotation of injection sites
2) When injecting within any one subregion, two consecutive injections should be systematically rotated at least 1 cm apart (or about the width of an adult's finger) to avoid repeated tissue trauma
.
3) From the beginning of injection treatment, patients should be taught an easy-to-follow rotation protocol
.
Adjust as
treatment progresses as needed.
Healthcare providers should evaluate the patient's site rotation protocol
at least once a year.
4) Patients should be taught how to self-check the injection site, how to rotate the injection site, the correct injection technique, and how to check and prevent fat hyperplasia
.
Figure 5 Guidelines recommend injection sites
Problem 3: Injection needles are reused
As mentioned earlier, each insulin injection requires the use of a new needle, but in practice, there are still many patients who reuse needle injection
.
The main reasons are that patients think that carrying needles with them is a burden, using new needles for each injection is a waste of resources, and are unwilling to carry special sharps to store containers
.
But in fact, repeated use of needles often brings a lot of harm:
Repeated needle use can affect the accuracy of the injection dose, because the used needle contains insulin crystals, which may block the needle and hinder the injection;
The needle after injection is left on the insulin pen, and it will also cause errors
in the dose of insulin due to thermal expansion and contraction.
Studies have shown that repeated needle reuse will cause the needle to be rolled up and pricked, resulting in bleeding at the injection site and increasing injection pain;
Pathogen contamination: the needle remains on the insulin pen and may cause air (or other contaminants) to enter the refill;
Risk of subcutaneous fat hyperplasia: subcutaneous fat hyperplasia is more frequent in patients who reuse needles
.
The main thing is to recognize the harm of reusing needles, as the number of needle reuse increases, the proportion of patients with poor blood sugar control also increases greatly, and blood sugar fluctuations, blood sugar is not easy to reach the standard, and the amount of insulin is increased, which will eventually lead to increased
costs.
Having said all this, how to regulate the injection of insulin? Quickly close the picture below, standardize the injection and don't get lost!
Figure 6 Follow the nine-step standard insulin injection
Professor Li Yanbing
- Professor, doctor of endocrinology, doctoral supervisor, famous doctor of Sun Yat-sen University
- Director of the Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University
- Director of the Key Laboratory of Endocrinology, Department of Health of Guangdong Province
- Chairman of the Endocrinology Branch of Guangdong Medical Association
- Vice Chairman of the Diabetes and Microcirculation Professional Committee of the Chinese Society of Microcirculation
- Member of Endocrinology Branch of Chinese Medical Association, Deputy Head of Pituitary Group
- Leader of the Chinese insulin secretion research group
- National medical leading talent in Guangdong Province
- Chief expert of the National Key Special Project for Major Chronic Diseases
- Guest Editor of J Diabetes Res, Guest Editor of Diabetes Metab Res Rev, Editorial Board Member of Chinese Journal of Diabetes, Editorial Board Member of Chinese Journal of Endocrinology and Metabolism, Associate Editor of Chinese Electronic Journal of Obesity and Metabolic Diseases
- Chairman of the third session of Diabetes Branch of Guangdong Medical Association
- Chairman of the Metabolism and Endocrinology Professional Committee of Guangdong Health Management Society
- Member of Guangdong Provincial Cadre Health Care Expert Group, Chief Expert of Guangdong Provincial Health Education
Li Hai
- Deputy Director of the Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University
- Deputy Chief Physician, Medical Doctor, Master Supervisor
- Vice Chairman of the Youth Committee of the Endocrinologist and Metabolism Branch of the Chinese Medical Doctor Association
- Member of the Pituitary Group of the Endocrinology Branch of the Chinese Medical Association
- Member of the Chinese Pituitary Adenoma Collaborative Group
- Secretary & Vice Chairman of Youth Committee of Endocrinology Branch of Guangdong Medical Association
- Vice Chairman of Diabetes and Endocrinology Professional Committee of Guangdong Association of Pharmaceutical Quality Management
Where to see more endocrinology clinical knowledge? Come to the "Doctor Station" and take a look 👇 at the references:[1] Luo Yingying, Ji Linong.
Analysis of misunderstanding of insulin injection technology and recommendation of international norms[J].
Chinese Journal of Diabetes,2011,03(3):267-270.
) Ji Linong, Guo Xiaohui, Jin J, et al.
Technical Guidelines for Diabetes Drug Injection in China (2016 Edition)[J].
Chinese Journal of Diabetes, 2017(2):79-105 [3] Chinese Journal of Diabetes Guidelines and Consensus Writing Committee.
Chinese Diabetes Drug Injection Technical Guidelines (2016 Edition)[J].
Chinese Journal of Diabetes,2017,9(2):79-105.
) [4] Diabetes Branch of Chinese Medical Association.
Chinese expert consensus on the prevention and treatment of subcutaneous lipoplasia associated with insulin injection[J].
Chinese Journal of Diabetes, 2021, 13(12):8